hsa-mir-1287: Hsa-mir-1287 is a microRNA that has been studied in various contexts [PMC4695119]. Overexpression of hsa-miR-657 and downexpression of hsa-mir-1287 have been shown to effectively distinguish between early larynx carcinoma and normal mucosa tissues, indicating their potential as biomarkers [PMC4695119]. Hsa-mir-1287 has also been found to regulate CD105 expression and control osteopotential in SHED (stem cells from human exfoliated deciduous teeth) [PMC8184333]. Additionally, a study demonstrated sequence conservation in hsa-mir-1287, as well as a novel candidate atypical mirtron miRNA (MELmiRNA_293) [PMC2837346]. Microarray-based screening revealed that hsa-miR-657 and hsa-mir-1287 are highly deregulated in early laryngeal carcinoma and normal esophageal mucosa tissues, suggesting their potential as diagnostic markers for laryngeal malignancies at early stages [PMC7279294]. Furthermore, microarray analysis identified a two-miRNA signature consisting of hsa-miR-657 and hsa-mir-1287 as an effective predictive biomarker for early diagnosis of laryngeal cancer [PMC5642505]. Additionally, the stable overexpression of hsa-miR-557 and hsa-mir-1287 has been shown to increase the production of IgG and recombinant human serum albumin in CHO cells [PMC8977551].